137 related articles for article (PubMed ID: 3492692)
1. Sensitivity of clinical bacterial isolates to Timentin (ticarcillin/clavulanic acid).
Villiger JW
N Z Med J; 1986 Nov; 99(814):914. PubMed ID: 3492692
[No Abstract] [Full Text] [Related]
2. In vitro activity of timentin.
Thomas MG; Lang SD
N Z Med J; 1985 May; 98(779):403-4. PubMed ID: 3857527
[No Abstract] [Full Text] [Related]
3. A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid.
Joly B; Chanal M; Sirot D; Cluzel M; Sirot J; Cluzel R
J Antimicrob Chemother; 1986 May; 17 Suppl C():27-33. PubMed ID: 3522530
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of piperacillin v timentin and ticarcillin.
Bremner DA
N Z Med J; 1987 May; 100(823):299-300. PubMed ID: 3138579
[No Abstract] [Full Text] [Related]
5. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
Branger C; Kitzis M; Le Mée J
Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
[TBL] [Abstract][Full Text] [Related]
6. Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates.
Griffin KE; Slocombe B
J Chemother; 1989 Jul; 1(4 Suppl):267-9. PubMed ID: 16312396
[No Abstract] [Full Text] [Related]
7. In vitro activity and disk susceptibility of Timentin: current status.
Fuchs PC; Barry AL; Jones RN
Am J Med; 1985 Nov; 79(5B):25-32. PubMed ID: 4073092
[No Abstract] [Full Text] [Related]
8. Development of beta-lactamase inhibitors.
Sutherland R
J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility-resistance patterns of bacterial isolates from burn patients to augmentin and timentin.
Holder IA; Vanderpool L; Wesselman J
J Burn Care Rehabil; 1985; 6(4):331-4. PubMed ID: 3879938
[No Abstract] [Full Text] [Related]
10. [Clinical evaluation of timentin in intensive care].
Gérard A; Dureux JB; Canton P; May T; Schmit JL
Pathol Biol (Paris); 1986 May; 34(5):448-50. PubMed ID: 3534719
[TBL] [Abstract][Full Text] [Related]
11. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
Traub WH; Spohr M
Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
[TBL] [Abstract][Full Text] [Related]
12. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
Sanders CV; Aldridge KE
J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of parenteral ticarcillin formulated with clavulanic acid: Timentin.
Staniforth DH; Coates PE; Davies BE; Horton R
Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):123-9. PubMed ID: 3699938
[TBL] [Abstract][Full Text] [Related]
14. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
Rouhan D; Le Noc P; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
Boon RJ; Beale AS; Sutherland R
Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods.
Chattopadhyay B; Hall I
Curr Med Res Opin; 1984; 9(3):157-60. PubMed ID: 6568146
[TBL] [Abstract][Full Text] [Related]
17. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.
Barry AL; Ayers LW; Gavan TL; Gerlach EH; Jones RN
Eur J Clin Microbiol; 1984 Jun; 3(3):203-6. PubMed ID: 6147246
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.
Fuchs PC; Barry AL; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1984 Mar; 25(3):392-4. PubMed ID: 6721472
[TBL] [Abstract][Full Text] [Related]
20. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
Thabaut A; Meyran M
Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]